Immune checkpoint inhibitor-mediated colitis in gastrointestinal malignancies and inflammatory bowel disease.

Weingarden, Alexa R; Rubin, Samuel J S; Gubatan, John

Weingarden, Alexa R; Rubin, Samuel J S; Gubatan, John.

Afiliação

Weingarden AR; Division of Gastroenterology and Hepatology, Department of Medicine, Stanford University, Redwood City, CA 94063, United States. aweingar@stanford.edu.
Rubin SJS; Stanford University School of Medicine, Stanford University, Redwood City, CA 94063, United States.
Gubatan J; Division of Gastroenterology and Hepatology, Department of Medicine, Stanford University, Redwood City, CA 94063, United States.

World J Gastrointest Oncol ; 13(8): 772-798, 2021 Aug 15.

Article em En | MEDLINE | ID: mdl-34457186

Palavras-chave

Cytotoxic T-lymphocyte antigen 4; Gastrointestinal cancer; Immune checkpoint inhibitors; Inflammatory bowel disease; Programmed cell death protein-1

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article